Life-Settlement Funds

How it works

A policyholder, typically older and often carrying a health impairment, sells an in-force life insurance policy for a price above what the insurer would pay to surrender it, but far below the face amount. The buyer, usually a fund, becomes the new owner and beneficiary, assumes responsibility for every future premium, and collects the death benefit when the policy matures, which is the industry's term for the death of the insured. Pricing rests on a life expectancy estimate from specialist medical underwriters who review the insured's records, combined with the policy's cost-of-insurance schedule and a discount rate chosen by the buyer.

Universal life policies dominate this market because their premiums are flexible. A fund can pay just enough to keep the policy from lapsing, and managing that minimum payment across a portfolio is a substantial part of the return. A premium reserve is set aside so the fund can keep policies in force if maturities arrive more slowly than modelled, and exhausting that reserve is how these funds fail.

Portfolios are built for diversification across insureds, ages, impairments, carriers and face amounts, since a small portfolio is effectively a bet on a handful of individual outcomes. Transactions are regulated at the state level in the US, with licensing for providers and brokers, mandatory disclosures, and rescission periods that protect the seller. Investors reach this asset through private funds, offshore vehicles with feeder structures, and occasionally fractional interests in individual policies, an access route regulators have repeatedly warned about.

What it pays

There is no coupon. Cash arrives only when a policy matures, so distributions are lumpy and unpredictable in timing even when a portfolio is performing exactly as modelled. The return itself is the gap between what the fund paid, plus every premium and servicing cost from purchase to maturity, and the face amount eventually collected. It is an accretion of value realized at an unknown date, not an income stream in the usual sense.

The dominant driver is longevity relative to the underwritten life expectancy. A maturity that arrives earlier than expected means fewer premiums paid and a shorter discounting period, and both effects push the realized return higher; the reverse is equally true. This risk is idiosyncratic and structurally unrelated to interest rates, equity markets or credit cycles, which is the principal argument made for holding the asset. That argument says nothing about how large or small the return will actually be.

Between maturities, reported net asset value is a model output, a discounting of expected cash flows using assumed life expectancies and a chosen rate, not a market price. Some funds build cash-flow-matched portfolios designed to smooth the timing of distributions, which reduces payment variability without touching the underlying mortality risk. Returns are consequently quoted as a target internal rate of return rather than a yield, since there is no periodic payment to annualize.

Costs and taxes

Acquisition costs are high. Broker commissions, provider fees, life expectancy reports and legal work all sit between what the original policyholder receives and what the fund actually pays for the policy. Ongoing costs are the premiums themselves, plus the servicing and tracking operation required to monitor each insured, on top of management and performance fees charged at the fund level.

US federal tax treatment is unusual here. The death benefit's normal tax-free status does not survive a sale of the policy: under the transfer-for-value rules, a purchaser is taxed on proceeds exceeding its basis in the policy. Whether that gain is ordinary or capital depends on the policy type and the holder's circumstances, and IRS guidance has shifted over time, so the analysis is specialised and fact-specific rather than a settled rule of thumb.

Many funds are domiciled offshore, which raises passive foreign investment company considerations for a US investor, usually addressed through tax elections or a US-domiciled feeder fund. Premiums paid increase the fund's basis in each policy, and a policy allowed to lapse produces a total loss of everything invested in it, premiums included. Tracking the insured is as much a compliance obligation as an economic one, since the fund must learn of a death to file a claim, and privacy rules constrain how that monitoring can be done.

Liquidity and time commitment

Capital is locked up for the life of the fund. Fund terms typically run for years, and money returns only as policies mature, on a schedule no manager controls or can accelerate. A tertiary market exists where portfolios of policies change hands between institutions, but it is negotiated privately, and the price reflects the buyer's own longevity and discount assumptions rather than any quoted market level.

Redemption provisions in open-ended vehicles have historically been the weak point. A fund forced to sell policies to meet redemption requests sells into a thin, negotiated market at a discount, which can penalize remaining investors. Fractional interests in individual policies are effectively unsellable and leave the holder liable for a share of ongoing premiums, sometimes with calls for additional money if the insured lives longer than expected.

Effort for a fund investor is low; the work of tracking insureds, servicing policies and optimising premium payments across the portfolio is intensive and specialised, but it is the manager's job, not the investor's. Access is generally restricted to accredited or institutional investors, and offering documents typically describe the position as suitable only for capital that can be held to the end of the fund's life.

How it goes wrong

The central failure mode is people living longer than the life expectancy report predicted. Every additional year of life means more premiums paid and a longer wait for the death benefit, and the industry has already been through an episode of systematically revising life expectancy assumptions, which repriced entire portfolios downward at once. When premium reserves run out under that pressure, policies lapse, and a lapsed policy is a total loss of the purchase price and every premium paid into it, the classic collapse scenario for an underfunded fund.

Carriers can raise the cost of insurance on universal life policies, forcing higher premiums to keep coverage in force; these increases have been extensively litigated by policyholders and funds alike. Some policies face contestability or insurable-interest challenges, particularly those originated as stranger-originated life insurance, and courts have divided on whether a voided policy requires premiums to be returned to the fund.

Because valuation is model-driven rather than market-priced, reported returns can drift upward on optimistic assumptions for years and then reset sharply when those assumptions are revised, with no independent price to check them against in the interim. A small portfolio concentrated in a few large policies is not diversified insurance risk but a direct wager on individual lives.

Retail mis-selling has a long enforcement history, with fractional interests sold to individual investors the subject of repeated SEC and state securities actions, often involving inflated life expectancy claims. Carrier credit matters as well: the death benefit is ultimately a claim on an insurance company, and a carrier in run-off or receivership can complicate and delay collection.